Found: 96
Select item for more details and to access through your institution.
Reflex sympathetic dystrophy in patients with metastatic renal cell carcinoma treated with Everolimus.
- Published in:
- 2010
- By:
- Publication type:
- Report
Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma.
- Published in:
- 2010
- By:
- Publication type:
- Report
Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 1, p. 17, doi. 10.3390/cells11010017
- By:
- Publication type:
- Article
Patient‐reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma.
- Published in:
- BJU International, 2020, v. 126, n. 1, p. 73, doi. 10.1111/bju.15058
- By:
- Publication type:
- Article
Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase II study.
- Published in:
- BJU International, 2019, v. 123, n. 5, p. 804, doi. 10.1111/bju.14581
- By:
- Publication type:
- Article
Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma.
- Published in:
- International Journal of Cancer, 2005, v. 117, n. 4, p. 596, doi. 10.1002/ijc.21264
- By:
- Publication type:
- Article
Analysis of the natural killer mediated immune response in metastatic renal cell carcinoma patients.
- Published in:
- International Journal of Cancer, 2004, v. 109, n. 3, p. 393, doi. 10.1002/ijc.11730
- By:
- Publication type:
- Article
Effects of infused intralipids on neutrophil chemotaxis during total parenteral nutrition.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Renal Cell Carcinoma: The Fastest Evolving Tumor.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 4, p. 396
- By:
- Publication type:
- Article
Emerging Efficacy Endpoints for Targeted Therapies in Advanced Renal Cell Carcinoma.
- Published in:
- Oncology (08909091), 2006, v. 20, p. 19
- By:
- Publication type:
- Article
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.
- Published in:
- Drugs, 2022, v. 82, n. 7, p. 719, doi. 10.1007/s40265-022-01703-5
- By:
- Publication type:
- Article
Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma.
- Published in:
- Drugs, 2020, v. 80, n. 12, p. 1169, doi. 10.1007/s40265-020-01327-7
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma.
- Published in:
- Drugs, 2018, v. 78, n. 14, p. 1443, doi. 10.1007/s40265-018-0970-y
- By:
- Publication type:
- Article
Targeted therapies in the management of renal cell carcinoma: role of bevacizumab.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 3, p. 517
- By:
- Publication type:
- Article
Overrepresentation of 7q31 and 17q in renal cell carcinomas.
- Published in:
- Genes, Chromosomes & Cancer, 1998, v. 22, n. 3, p. 171, doi. 10.1002/(SICI)1098-2264(199807)22:3<171::AID-GCC2>3.0.CO;2-T
- By:
- Publication type:
- Article
Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 93, doi. 10.1093/jnci/djr511
- By:
- Publication type:
- Article
Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 20, p. 1454, doi. 10.1093/jnci/djn319
- By:
- Publication type:
- Article
Optimal Management of Metastatic Renal Cell Carcinoma: Current Status.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Vascular Endothelial Growth Factor-Targeted Therapy for the Treatment of Renal Cell Carcinoma.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Advanced Renal Cell Carcinoma: Current and Emerging Management Strategies.
- Published in:
- Drugs, 2007, v. 67, n. 9, p. 1257, doi. 10.2165/00003495-200767090-00002
- By:
- Publication type:
- Article
T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccines.
- Published in:
- International Journal of Cancer, 1997, v. 71, n. 6, p. 972, doi. 10.1002/(SICI)1097-0215(19970611)71:6<972::AID-IJC11>3.0.CO;2-8
- By:
- Publication type:
- Article
In situ demonstration of renal-cell-carcinoma-specific T-cell clones.
- Published in:
- International Journal of Cancer, 1996, v. 66, n. 4, p. 564, doi. 10.1002/(SICI)1097-0215(19960516)66:4<564::AID-IJC23>3.0.CO;2-6
- By:
- Publication type:
- Article
Low-dose IL-2 treatment: Activation of discrete T- and NK-cell sub-populations in vivo.
- Published in:
- International Journal of Cancer, 1995, v. 62, n. 5, p. 523, doi. 10.1002/ijc.2910620506
- By:
- Publication type:
- Article
The decreased expression of CD3 ζ chains in cancer patients is not reversed BY IL-2 Administration.
- Published in:
- International Journal of Cancer, 1994, v. 59, n. 6, p. 752, doi. 10.1002/ijc.2910590607
- By:
- Publication type:
- Article
Metastatic renal-cell carcinoma patients treated with interleukin 2 or interleukin 2 plus interferon γ: Immunological monitoring.
- Published in:
- International Journal of Cancer, 1994, v. 57, n. 6, p. 814, doi. 10.1002/ijc.2910570609
- By:
- Publication type:
- Article
Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma.
- Published in:
- International Journal of Cancer, 1993, v. 54, n. 5, p. 741, doi. 10.1002/ijc.2910540506
- By:
- Publication type:
- Article
Analysis of T-cell-receptor variable gene segment usage in peripheral-blood lymphocytes of advanced cancer patients.
- Published in:
- International Journal of Cancer, 1993, v. 54, n. 1, p. 60, doi. 10.1002/ijc.2910540111
- By:
- Publication type:
- Article
Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Local recurrence after radical nephrectomy for kidney cancer: management and prediction of outcomes. a multi-institutional study.
- Published in:
- Journal of Surgical Oncology, 2014, v. 109, n. 2, p. 126, doi. 10.1002/jso.23473
- By:
- Publication type:
- Article
Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2022, v. 13, n. 5, p. 2405, doi. 10.1002/jcsm.13021
- By:
- Publication type:
- Article
Subungual splinter hemorrhages: a clinical window to inhibition of vascular endothelial growth factor receptors?
- Published in:
- 2005
- By:
- Publication type:
- letter
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: Phase II randomized study comparing two dose levels.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 289, doi. 10.1038/sj.cgt.7700441
- By:
- Publication type:
- Article
Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 254, doi. 10.1093/oncolo/oyad348
- By:
- Publication type:
- Article
Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated with Axitinib: Subgroup Analysis from TIVO-3.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. e167, doi. 10.1093/oncolo/oyac255
- By:
- Publication type:
- Article
The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 389, doi. 10.1002/onco.13711
- By:
- Publication type:
- Article
The Current and Evolving Landscape of First‐Line Treatments for Advanced Renal Cell Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 338, doi. 10.1634/theoncologist.2018-0267
- By:
- Publication type:
- Article
Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 667, doi. 10.1634/theoncologist.2016-0435
- By:
- Publication type:
- Article
Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma.
- Published in:
- Oncologist, 2017, v. 22, n. 1, p. 41, doi. 10.1634/theoncologist.2016-0197
- By:
- Publication type:
- Article
Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma--Analysis Using Diagnostic Nodes.
- Published in:
- Oncologist, 2015, v. 20, n. 9, p. 1028, doi. 10.1634/theoncologist.2015-0145
- By:
- Publication type:
- Article
Non-Clear Cell Renal Cell Carcinoma: Does the Mammalian Target of Rapamycin Represent a Rational Therapeutic Target?
- Published in:
- Oncologist, 2012, v. 17, n. 8, p. 1051, doi. 10.1634/theoncologist.2012-0038
- By:
- Publication type:
- Article
Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα.
- Published in:
- PLoS ONE, 2009, v. 4, n. 3, p. 1, doi. 10.1371/journal.pone.0004942
- By:
- Publication type:
- Article
Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 11, p. 2085, doi. 10.1002/cncr.34180
- By:
- Publication type:
- Article
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial.
- Published in:
- Journal of Translational Medicine, 2005, v. 3, p. 10, doi. 10.1186/1479-5876-3-10
- By:
- Publication type:
- Article
Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?
- Published in:
- World Journal of Urology, 2014, v. 32, n. 1, p. 109, doi. 10.1007/s00345-013-1088-1
- By:
- Publication type:
- Article
Comments on the article “Targeted therapy in renal cell carcinoma” by J.-J. Patard et al.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie.
- Published in:
- World Journal of Urology, 2005, v. 23, n. 3, p. 161, doi. 10.1007/s00345-004-0467-z
- By:
- Publication type:
- Article
Standard of Care for Patients with Metastatic Renal Cell Carcinoma (mRCC) in 2014: An Overview.
- Published in:
- Journal of OncoPathology, 2014, v. 2, n. 4, p. 1, doi. 10.13032/tjop.2052-5931.100114
- By:
- Publication type:
- Article
Feasibility and oncological outcomes of laparoscopic treatment for local relapse of renal cell carcinoma.
- Published in:
- BJU International, 2013, v. 112, n. 4, p. E307, doi. 10.1111/j.1464-410X.2012.11724.x
- By:
- Publication type:
- Article